Jim Armitage, M.D.
Dr. James O. Armitage, a graduate of the University of Nebraska Medical Center, completed his internship and residency in internal medicine at Nebraska, a fellowship in hematology oncology at the University of Iowa and spent 2 years in private practice. He returned to the University of Iowa and developed and directed the Bone Marrow Transplant program. At the University of Nebraska Medical Center, he developed the Bone Marrow Transplant program and the Nebraska Lymphoma Study Group. At Nebraska he has served as Vice-Chair of Internal Medicine, Chief of the Section of Oncology and Hematology, Chair of the Department of Internal Medicine, and Dean of the College of Medicine. He currently is the Joe Shapiro Professor of Medicine at the University of Nebraska Medical Center. Dr. Armitage is board certified in internal medicine, medical oncology, and hematology, and a Fellow of both the American and the Royal College of Physicians, a Fellow of ASCO, and a Fellow of the American Association for the Advancement of Science, and a Fellow of ASTCT (American Society for Transplantation and Cellular Therapy). He has served on many national/international oncology committees including the United States National Cancer Advisory Board and the French National Cancer Advisory Board. He is past president of both the American Society of Clinical Oncology and the American Society of Blood and Marrow Transplantation.
He has received numerous honors including the Claude Jacquillat Award for achievement in Clinical Oncology from Paris, the San Salvatore Foundation Research Award from Lugano, Switzerland, The Richard and Hinda Rosenthal Foundation Award from the American Association of Cancer Research, the Heath Memorial Award from the University of Texas MD Anderson Cancer Center, The Robert A. Kyle Award for Outstandning Clinical Scientist from the Mayo Clinic, The Special Recognition Award from ASCO, and election to the Association of American Physicians. Dr. Armitage has published more than 600 papers, written 116 chapters, and is editor/co-editor of 33 books. He currently edits the ASCO Post.
Financial relationships
-
Attribution:SelfType of financial relationship:Stock OptionsIneligible company:cardiff oncologyTopic:board memberDate added:01/02/2024Date updated:01/02/2024